Please login to the form below

Not currently logged in
Email:
Password:

South Africa to spend USD 688.2m on HIV drugs

The South African government's department of trade and industry (DTI) has announced it will spend about ZAR 5bn (USD 688.2m) on anti-retrovirals (ARVs) in the next three years to augment domestic production of the drugs.

The South African government's department of trade and industry (DTI) has announced it will spend about ZAR 5bn (USD 688.2m) on anti-retrovirals (ARVs) in the next three years to augment domestic production of the drugs.

According to the Medical Research Council, 5.4m people are living with HIV/Aids in South Africa, which is the second most infected population after India.

The DTI added that increased local production of ARVs would make it economically viable for pharmaceutical companies to manufacture them locally and reduce associated costs. At the moment, active pharmaceutical ingredients (APIs) for making ARVs are imported, pushing up running costs for manufacturing plants in the region.

Andrew Kudlinski, director for geographic projects at the DTI, said: "Manufacturing ARVs involves complex technology and is costly. A company must make large volumes to make it economically justifiable and if you have a three-year contract, the manufacturer can justify the investment.î

"South Africa has the capacity to manufacture most ARVs locally but 100 percent of the active pharmaceuticals ingredients are imported and we can use state procurement to encourage the domestic manufacturing of APIs in the future," added Kudlinski.

Nimrod Zalk, the DTI's chief director of industrial policy, explained that the government was concerned about the import ratio in the drugs sector, which was worth ZAR 17.7 billion in 2006.

29th August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...